Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

NCT07081360 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

262

Enrollment

OTHER

Sponsor class

Conditions

Pancreas Cancer
Periampullary Cancer
Periampullary Carcinoma Resectable
Pancreatic Cancer Resectable
Ampullary Cancer
Pancreas Adenocarcinoma

Interventions

DRUG: Neoadjuvant chemotherapy
PROCEDURE: Upfront Surgery Group

Sponsor

Minia University